I am doing a market analysis of the newborn jaundice management market
- in particular, I am trying to get a sense of the potential future
for Natus Medical's neoBLUE product.  Can someone answer the following
questions regarding this market:

How much money is spent annually in this market to treat jaundice?

What does the average sale look like (in other words, how much does
the equipment cost?  how many units will the average hospital buy? 
how does a hospital decide on a particular product)?

Who are the competitors?

What is the market share, per product?

How fast is the market growing?

What are possible technological innovations from this point?

(The amount of my tip will vary between $0 - $100 based on quality and
depth of answer.  I'm looking for sources independent of investor
relations at Natus).